期刊： HEPATOLOGY RESEARCH, 2022; 52 (3)
Purpose To assess the impact of clinical factors on the safety and efficacy of atezolizumab plus bevacizumab (ATZ + BV) treatment in patients with unr......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (3)
Background Atezolizumab plus bevacizumab was approved for hepatocellular carcinoma (HCC) patients in 2020, but treatment outcomes of atezolizumab plus......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (5)
Aim The present study focused on the association of early bevacizumab (Bev) interruption with the clinical outcome of atezolizumab plus bevacizumab. M......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (10)
Background & Purpose Protease-free regimens for chronic hepatitis C virus (HCV) infection are safe and effective for persons with either compensat......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (12)
Aim Recently, a new technique using attenuation imaging (ATI) was developed to diagnose hepatic steatosis. The aim of this study was to investigate wh......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (5)
Recently, international expert panels have proposed a new definition of fatty liver: metabolic dysfunction-associated fatty liver disease (MAFLD). MAF......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (4)
Aim Accurate detection of the hepatic fibrosis stage is essential to estimate the outcome of patients with non-alcoholic fatty liver disease (NAFLD). ......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (8)
Background and Aims Although patients with chronic liver disease (CLD) usually show few symptoms, they exhibit decreased health-related QOL (HRQOL) wi......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (12)
Aim: Carbon-ion radiotherapy (C-ion RT) has shown potential as a curative treatment for patients with hepatocellular carcinoma (HCC). However, no repo......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (4)
Aim Acute-on-chronic liver failure (ACLF) is associated with a high risk of short-term mortality after progression to multiple organ failure. A disint......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (5)
Background Biliary atresia (BA) is among the commonest indications for liver transplantation (LT) in children. We examined whether serum matrix metall......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (7)
Aim: Some autoimmune hepatitis (AIH) patients experience relapse during their clinical course, and some risk factors for relapse have been identified ......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (8)
Aim Fatty liver index (FLI), which is calculated by using body mass index, waist circumference and levels of gamma-glutamyl transferase and triglyceri......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (10)
Aim: Hepatitis B flare has been interpreted as result of immune response against upsurging hepatitis B virus (HBV) and its antigen(s) that may lead to......
期刊： HEPATOLOGY RESEARCH, 2022; 52 (10)
Aim Liver transplantation (LT) is the only curative therapy for decompensated liver cirrhosis. For recipients of living donor LT (LDLT), restoration o......
